New Device for Enhancement of Liposomal Magnetofection Efficiency of Cancer Cells

Liposomal magnetofection is the most powerful nonviral method for the nucleic acid delivery into the cultured cancer cells and widely used for in vitro applications. Use of the static magnetic field condition may result in non-uniform distribution of aggregate complexes on the surface of cultured cells. To prevent this, we developed the new device which allows to concentrate aggregate complexes under dynamic magnetic field, assisting more contact of these complexes with cellular membrane and, possibly, stimulating endocytosis. Newly developed device for magnetofection under dynamic gradient magnetic field, “DynaFECTOR", was used to compare transfection efficiency of human liver hepatocellular carcinoma cell line HepG2 with that obtained by lipofection and magnetofection. The effect of two parameters on transfection efficiency, incubation time under dynamic magnetic field and rotation frequency of magnet, was estimated. Liposomal magnetofection under dynamic gradient magnetic field showed the highest transfection efficiency for HepG2 cells.

• M. Baryshev
• D.Vainauska
• S. Kozireva
• A.Karpovs

• Dynamic magnetic field
• Lipofection
• Magnetofection

[1] F. Scherer, M Anton, U Schillinger, J Henke1, C Bergemann, A Kruger,
B Gansbacher and C Plank, Gene Therapy (2002) 9, 102-109.
[2] F. Krötz, C. De Wit, H.Y. Sohn, Zahler S, Gloe T, Pohl U, et al.,
Magnetofection - a highly efficient tool for antisense oligonucleotide
delivery in vitro and in vivo. Mol Ther 2003;7:700-10.
[3] S. Huth, J. Lausier, S.W. Gersting, C.Rudolph, C.Plank, U. Welsch et al.
Insights into the mechanism of magnetofection using PEI-based
magnetofectins for gene transfer. J Gene Med 2004;6:923-36.
[4] A. M. Sauer, K. G. de Bruin , N. Ruthardt, O. Mykhaylyk, C. Plank, C.
Bräuchle. Dynamics of magnetic lipoplexes studied by single particle
tracking in living cells. J Control Release 2009;137:136-45.
[5] C. Plank, M. Anton, C. Rudolph, J. Rosenecker, F. Krotz. Enhancing
and targeting nucleic acid delivery by magnetic force. Expert Opin Biol
Ther 2003;3:1-14..
[6] N. Morishita., H. Nakagami, R. Morishita, S. Takeda, F. Mishima, B.
Terazono, et al. Magnetic nanoparticles with surface modification
enhanced gene delivery of HVJ-E vector. Biochem Biophys Res
Commun 2005;334:1121-6.
[7] E.P. Furlani, K.C. Ng. Nanoscale magnetic biotransport with application
to magnetofection. Phys Rev E 2008;77:1-8.
[8] S.W. Kamau, P.O. Hassa, B. Steitz, A. P. Fink, H. Hofmann, M.
Hofmann-Amtenbrink, et al. Enhancement of the efficiency of non-viral
gene delivery by application of pulsed magnetic field. Nucleic Acids Res
2006;34:e40.
[9] S.C. McBain, U. Griesenbach, S. Xenariou, A. Keramane, C.D. Batich,
E..W.F.W, Alton, et al. Magnetic nanoparticles as gene delivery agents:
enhanced transfection in the presence of oscillating magnet arrays.
Nanotechnology 2008;19:405102.
[10] E.P. Furlani, Magnetic biotransport: analysis and aplplication. Materials
2010, 3, 2412-2446.